How Clinicians Manage Their Patients Who May Need Antithrombotic Care
1 other identifier
observational
2,500
0 countries
N/A
Brief Summary
This study aims to assess the knowledge and provide an opportunity for education to clinician attendees of the Canadian Cardiovascular Congress (CCC) meeting using a series of simulated patient case scenarios.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2023
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 14, 2023
CompletedFirst Posted
Study publicly available on registry
June 28, 2023
CompletedStudy Start
First participant enrolled
October 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedJuly 21, 2023
July 1, 2023
1 month
June 14, 2023
July 20, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Adherence to Clinical Practice Guideline Recommendations
Open-ended recommendations provided by all participants on how they would treat each patient case in each scenario will be qualitatively coded as follows: 1) adhering to the recommendations provided in the guidelines, 2) partly adhering the recommendations provided in the guidelines, and 3) not adhering to the recommendations provided in the guidelines. For each participant, a total score will be computed across all case scenarios to determine adherence level to the latest Canadian clinical practice guideline recommendations.
1-Month.
Eligibility Criteria
By convenience, there will be approximately 5,000 attendees at this conference and it is expected that no more than 50% will participate in this study. Therefore, the expected total number of participants is 2,500.
You may qualify if:
- Any clinician (i.e., licensed medical doctor, nurse practitioner) attending the CCC's 2023 event from October 25th-29th, 2023 will be included in this endeavour so long as they have the ability to provide informed consent (i.e., can read, write, and understand the English language).
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Anthony Tanglead
Related Publications (1)
Antiperovitch P, Liu I, Mokhtar AT, Tang A. Evaluating Large Language Models in Cardiovascular Antithrombotic Care: Performance, Accuracy, and Implications for Clinical Practice. Can J Cardiol. 2025 Aug;41(8):1584-1591. doi: 10.1016/j.cjca.2025.04.008. Epub 2025 Apr 15.
PMID: 40239865DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor and Scientific Director
Study Record Dates
First Submitted
June 14, 2023
First Posted
June 28, 2023
Study Start
October 1, 2023
Primary Completion
November 1, 2023
Study Completion
December 1, 2023
Last Updated
July 21, 2023
Record last verified: 2023-07